Synthaverse S.A.

zł 2.59As of Sun 8 Nov 2026, 12:00 UTC
WSE:SVEHealthcare
Country Poland
PE (Fwd) •••
TSR 10Y CAGR 9.85%
Div yield —
ROE (17.86%)
Biotechnology
Beta (5Y) (0.07)
PE TTM —
TSR TTM (36.83%)
Mkt cap zł 196.9M
ROIC (8.18%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
zł 2.57
(0.72%)
(7.51%)
Sell 1|9|5|2|6
4Q25
1Q26
2Q26
3Q26
Earnings per sharezł
0.03
0.04
0.03
0.04
27.19%
23.38%
11.59%
14.64%
Revenuezł M
11.52
11.19
11.84
12.29
19.80%
9.90%
11.34%
12.68%
Peers (US$49.72M)
Cap (US$)
PE
75.03M
—
31.51M
—
28.93M
—
49.81M
—
Capital
TTM
5Y
10Y
Leveragex
3.559
1.116
0.882
EBIT/Intx
0.624
1.081
0.974
Own earn%
106.25
19.02
21.05
Sh yield%
31.79
59.32
61.02
Owners
Insiders/Inst%
11.52
42.49
Short interest%
2.51
SBC / revenue%
0.24
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
14
Op margin range%
0–7
$1 testx
−0.3
Incr. ROIC%
7